Veeva Crossix for Emerging Biotechs
Maximize the Impact of Every DTC and
HCP Marketing Dollar
See how emerging biotechs and small to mid-size biopharmas leverage Crossix to optimize media plans, validate spend, and reach the right patients.
Corcept Therapeutics: Validating and Optimizing Media with Marketing Analytics
Watch how Corcept Therapeutics uses a unified view of campaigns to optimize media in real-time and validate their marketing investments.
Rare Disease Marketing: 4 Media Strategies for Reaching Patients and HCPs
Rare disease marketers from Takeda and Immunocore share how they use Crossix data to precisely reach patients and their HCPs.
5 Tips for Emerging Biotechs: How to Maximize HCP and DTC Media Investments
Learn how Corcept Therapeutics and Dynavax Technologies are using Crossix data to drive informed decisions and prove the impact of every dollar.
Marketing in Rare Disease: Insights from Alexion Pharmaceuticals, Amgen, and Teva Pharmaceuticals
Rare disease marketers share their patient-centric approaches to engaging rare disease populations.
4 Steps for Effectively Marketing New Treatments
Explore four essential steps for marketing new treatments, with actionable tips to optimize media plans and manage stakeholder expectations.
Case Study: A Rare Disease Brand Uses Marketing Analytics to Improve Campaign Performance
A rare disease brand partnered with Veeva Crossix to see a 52% improvement in the cost per qualified patient reached, without increasing media spend.
5 Things to Look For in a Marketing Analytics Partner
Review a helpful list for biopharma marketers to evaluate potential marketing analytics partners.
Marketing New Treatments: How to Maximize Impact with Data-Driven Optimizations
Navigate launch complexities by tying tactics to health outcomes. Use audience quality metrics to validate strategy and secure future investment.